Ligua Valuation

Is 7090 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 7090 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 7090 (¥1080) is trading below our estimate of fair value (¥17928.35)

Significantly Below Fair Value: 7090 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 7090?

Key metric: As 7090 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 7090. This is calculated by dividing 7090's market cap by their current earnings.
What is 7090's PE Ratio?
PE Ratio	16.6x
Earnings	JP¥96.00m
Market Cap	JP¥1.60b

7090 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.7x
Enterprise Value/EBITDA	10.8x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 7090's PE Ratio compare to its peers?

The above table shows the PE ratio for 7090 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	17.8x
189A D & M Company	10.9x	n/a	JP¥1.9b
9214 Recovery InternationalLtd	21.4x	n/a	JP¥1.9b
6029 Artra Group	21.9x	n/a	JP¥1.3b
2435 CEDAR.Co.Ltd	16.9x	n/a	JP¥2.6b
7090 Ligua	16.6x	n/a	JP¥1.6b

Price-To-Earnings vs Peers: 7090 is good value based on its Price-To-Earnings Ratio (16.6x) compared to the peer average (17.8x).

Price to Earnings Ratio vs Industry

How does 7090's PE Ratio compare vs other companies in the JP Healthcare Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 7090 is expensive based on its Price-To-Earnings Ratio (16.6x) compared to the JP Healthcare industry average (14.8x).

Price to Earnings Ratio vs Fair Ratio

What is 7090's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

7090 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	16.6x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 7090's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Daiken Medical

JP¥14.7b

Engages in the manufacture and distribution of medical devices and equipment in Japan and internationally.

7775

JP¥512.00

2.0%

-0.8%

Suzuken

JP¥383.2b

Primarily engages in the distribution of pharmaceuticals in Japan and internationally.

9987

JP¥4,775.00

0.2%

-4.4%

TOKAI

JP¥74.5b

Provides various healthy life services in Japan.

9729

JP¥2,213.00

0.05%

18.2%